Ikarian Capital, LLC Cortexyme, Inc. Transaction History

Ikarian Capital, LLC

$573 Million
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$11.35 - $97.17 $228,816 - $1.96 Million	-20,160 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$52.0 - $120.21 $19,396 - $44,838	-373 Reduced 1.82%	20,160 $1.85 Million
Q2 2021 Aug 16, 2021	BUY	$31.88 - $58.66 $654,592 - $1.2 Million	20,533 New	20,533 $1.09 Million
Q1 2021 May 17, 2021	SELL	$28.6 - $49.21 $371,800 - $639,730	-13,000 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$27.78 - $56.93 $750,060 - $1.54 Million	-27,000 Reduced 67.5%	13,000 $361,000
Q3 2020 Nov 16, 2020	BUY	$39.85 - $57.3 $1.59 Million - $2.29 Million	40,000 New	40,000 $2 Million
Q2 2020 Aug 14, 2020	SELL	$34.93 - $57.75 $873,250 - $1.44 Million	-25,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$29.01 - $72.51 $725,250 - $1.81 Million	25,000 New	25,000 $1.14 Million

Others Institutions Holding CRTX

# of Institutions

39

Shares Held

5.21M

Call Options Held

90.8K

Put Options Held

0

Vanguard Group Inc Valley Forge, PA

1.2M
Shares

$1.55 Million
0.0% of portfolio
Epiq Capital Group, LLC San Francisco, CA

826K
Shares

$1.07 Million
0.32% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

523K
Shares

$674,123
0.0% of portfolio
Almitas Capital LLC Santa Monica, CA

383K
Shares

$493,917
0.23% of portfolio
Black Rock Inc. New York, NY

355K
Shares

$457,676
0.0% of portfolio

About Cortexyme, Inc.

Ticker CRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,150,800
Market Cap $70.5M

More about CRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.